Venture Capital Investors

Simulations Plus

venture capital investment firm Simulations Plus provides capital to innovative tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

To create value for our customers by accelerating and reducing the costs of R&D through innovative science-based software and consulting solutions that optimize treatment options and improve patient lives. Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/28/2025

Transaction History

Our records indicate that Simulations Plus invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Shawn O'Connor

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Simulations Plus has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Simpson Strong-Tie | Sinai Ventures

Share this article

About Our Venture Capital Investor Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary